InduPro

Biotech · Seattle, WA · Founded 2022 · Privately Held (backing)

Operator of a biopharma company intended to manipulate protein pairings via induced protein proximity to create novel signaling pathways and logic gates. InduPro is based in Seattle, WA and was founded in 2022. Its last reported valuation was $125 million in Jun 2024. It has raised $85 million across 2 recorded rounds; the latest was a $77 million Series B in Aug 2026.

Last reported valuation
$124.5M
Oct 2026
Priced at
—
Total raised
$85.0M
Last round
Series B
Aug 2026

Who backs InduPro?

8 investors
InvestorType
The EngineOther
Emerson CollectiveOther
Euclidean CapitalFamily office
Eli Lilly—
MRL Ventures Fund—
Sanofi—
The Column Group—
Vida Ventures (Los Angeles)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

InduPro investors

8 investors are on record for InduPro, including The Engine, Emerson Collective, Euclidean Capital and Eli Lilly.

Free account
More of InduPro with a free account
  • ·Watch InduPro: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like InduPro in biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View